Human polyomavirus 2
Human Polyomavirus 2, also known as JC virus, is a type of polyomavirus that infects humans. It is a member of the Polyomaviridae family and is known for its ability to cause progressive multifocal leukoencephalopathy (PML), a rare and often fatal demyelinating disease of the central nervous system.
Discovery and Classification
Human Polyomavirus 2 was first isolated in 1971 from the brain of a patient with PML. It is classified under the genus Betapolyomavirus within the family Polyomaviridae. The virus is named "JC" after the initials of the patient from whom it was first isolated.
Structure
The virus is a small, non-enveloped virus with a circular double-stranded DNA genome. The capsid is icosahedral in shape and composed of 72 capsomers. The genome encodes for several proteins, including the T-antigens, which are crucial for viral replication and transformation.
Epidemiology
Human Polyomavirus 2 is widespread in the human population, with seroprevalence rates ranging from 50% to 80% in adults. Primary infection typically occurs in childhood and is usually asymptomatic. The virus remains latent in the kidneys and other tissues.
Pathogenesis
In immunocompromised individuals, such as those with HIV/AIDS or those undergoing immunosuppressive therapy, the virus can reactivate and cause PML. The reactivation leads to the destruction of oligodendrocytes, resulting in demyelination and neurological symptoms.
Clinical Manifestations
The primary disease associated with Human Polyomavirus 2 is progressive multifocal leukoencephalopathy. Symptoms of PML include:
- Weakness or paralysis
- Vision problems
- Cognitive impairment
- Speech difficulties
Diagnosis
Diagnosis of Human Polyomavirus 2 infection is typically made through detection of viral DNA in the cerebrospinal fluid using polymerase chain reaction (PCR). Brain imaging, such as MRI, can also support the diagnosis by revealing characteristic lesions.
Treatment
There is currently no specific antiviral treatment for Human Polyomavirus 2. Management of PML involves restoring immune function, such as through antiretroviral therapy in HIV-positive patients. Experimental treatments are being investigated, but none have been conclusively proven effective.
Prevention
Preventive measures focus on maintaining immune function to prevent reactivation of the virus. This includes careful management of immunosuppressive therapies and monitoring of at-risk patients.
Related Pages
Human_polyomavirus_2
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD